Morten Tulstrup
Overview
Explore the profile of Morten Tulstrup including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Windfeld-Mathiasen J, Tulstrup M, Heerfordt I, Dalhoff K, Andersen J, Horwitz H
Ann Emerg Med
. 2025 Mar;
PMID: 40047772
Study Objective: This study investigated the 1-year risk of injuries and poisonings among anabolic androgenic steroid users compared with controls from the general population. Methods: In a cohort study conducted...
2.
Kaastrup K, Tulstrup M, Hansen J, Schollkopf C, Raaschou-Jensen K, Orskov A, et al.
Haematologica
. 2025 Jan;
PMID: 39744828
Not available.
3.
Heerfordt I, Tulstrup M, Horwitz H
J Am Acad Dermatol
. 2024 Nov;
92(3):583-585.
PMID: 39505272
No abstract available.
4.
Husby S, Tulstrup M, Harslof M, Nielsen C, Haastrup E, Ebbesen L, et al.
Leukemia
. 2024 Sep;
38(11):2456-2465.
PMID: 39223296
Mosaic chromosomal alterations (mCAs) in hematopoietic cells increase mortality and risk of hematological cancers and infections. We investigated the landscape of mCAs and their clinical consequences in 976 patients with...
5.
Sequeros C, Tulstrup M, Bliddal S, Sorensen K, Nissen I, Rezahosseini O, et al.
Hemasphere
. 2024 Mar;
8(3):e58.
PMID: 38463443
No abstract available.
6.
Wedge E, Ahmadov U, Hansen T, Gao Z, Tulstrup M, Come C, et al.
Leukemia
. 2023 Mar;
37(5):1113-1125.
PMID: 36922625
Mutations in U2AF1 are relatively common in myelodysplastic neoplasms (MDS) and are associated with an inferior prognosis, but the molecular mechanisms underlying this are not fully elucidated. Circular RNAs (circRNAs)...
7.
Soerensen M, Tulstrup M, Hansen J, Weischenfeldt J, Gronbaek K, Christensen K
Hemasphere
. 2022 Sep;
6(9):e768.
PMID: 36046215
Clonal hematopoiesis of indeterminate potential (CHIP) is common in the elderly and has been reported to associate with accelerated epigenetic age (AgeAccel), especially intrinsic (ie, cell-type independent) AgeAccel and to...
8.
Traeden D, Tulstrup M, Cowland J, Sjo L, Bogsted M, Gronbaek K, et al.
Blood Adv
. 2022 Apr;
6(11):3541-3550.
PMID: 35427424
Bone marrow specimens are the core of the diagnostic workup of patients with cytopenia. To explore whether next-generation sequencing (NGS) could be used to rule out malignancy without bone marrow...
9.
Nielsen R, Wolthers B, Helenius M, Albertsen B, Clemmensen L, Nielsen K, et al.
J Pediatr Hematol Oncol
. 2022 Feb;
44(3):e628-e636.
PMID: 35226426
Asparaginase-associated pancreatitis (AAP) frequently affects children treated for acute lymphoblastic leukemia (ALL) causing severe acute and persisting complications. Known risk factors such as asparaginase dosing, older age and single nucleotide...
10.
Tulstrup M, Soerensen M, Hansen J, Gillberg L, Needhamsen M, Kaastrup K, et al.
Nat Commun
. 2021 Oct;
12(1):6061.
PMID: 34663818
Mutations in the epigenetic modifier TET2 are frequent in myeloid malignancies and clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of undetermined significance (CCUS). Here, we investigate associations between...